John A Deford
Orang Dalam
Pengajuan SEC Pertama: 4 Nov. 2024 · Terbaru: 4 Nov. 2024
Orang Dalam di
Transaksi orang dalam
0 beli (P)
0 jual (S)
Bersih: $0
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 31 Juli 2026 | NDSN | A | 84 | $297,78 | $25.014 | 5.902 Langsung | +1,44% | Diakuisisi | 12,0% (harga per 2026-10-02) |
| 26 Mei 2026 | MRVI | A | 46.293 | · | · | 205.478 Langsung | +29,08% | Diakuisisi | (harga per 2026-10-02) |
| 30 April 2026 | NDSN | A | 87 | $288,45 | $25.095 | 5.802 Langsung | +1,52% | Diakuisisi | 15,6% (harga per 2026-10-02) |
| 30 Jan. 2026 | NDSN | A | 91 | $274,53 | $24.982 | 5.697 Langsung | +1,62% | Diakuisisi | 21,5% (harga per 2026-10-02) |
| 21 Jan. 2026 | GMED | A | 15.000 | · | · | 15.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 1 Nov. 2025 | NDSN | A | 822 | $231,95 | $190.663 | 5.587 Langsung | +17,25% | Diakuisisi | 43,8% (harga per 2026-10-02) |
| 16 Juni 2025 | MRVI | A | 89.139 | $2,16 | $192.540 | 159.185 Langsung | +127,26% | Diakuisisi | 265,7% (harga per 2026-10-02) |
| 23 Jan. 2025 | GMED | A | 15.000 | · | · | 15.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 12 Nov. 2024 | MRVI | P | 17.500 | $5,75 | $100.625 | 70.046 Langsung | +33,30% | Diakuisisi | 37,4% (harga per 2026-10-02) |
| 1 Nov. 2024 | NDSN | A | 747 | $249,03 | $186.025 | 4.694 Langsung | +18,93% | Diakuisisi | 33,9% (harga per 2026-10-02) |
| 23 Mei 2024 | MRVI | A | 20.645 | $10,78 | $222.553 | 52.546 Langsung | +64,72% | Diakuisisi | -26,7% (harga per 2026-10-02) |
| 26 Jan. 2024 | GMED | A | 15.000 | · | · | 15.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 1 Nov. 2023 | NDSN | A | 749 | $211,52 | $158.428 | 3.896 Langsung | +23,80% | Diakuisisi | 57,7% (harga per 2026-10-02) |
| 31 Okt. 2023 | NDSN | A | 105 | $212,59 | $22.322 | 3.147 Langsung | +3,45% | Diakuisisi | 56,9% (harga per 2026-10-02) |
| 1 Sep. 2023 | GMED | A | 15.000 | · | · | 15.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 1 Sep. 2023 | GMED | A | 15.578 | · | · | 15.578 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 1 Sep. 2023 | GMED | A | 15.000 | · | · | 15.000 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 1 Sep. 2023 | GMED | A | 15.578 | · | · | 15.578 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 31 Juli 2023 | NDSN | A | 89 | $251,61 | $22.393 | 3.034 Langsung | +3,02% | Diakuisisi | 32,6% (harga per 2026-10-02) |
| 20 Juli 2023 | MRVI | A | 31.901 | · | · | 31.901 Langsung | · | Diakuisisi | (harga per 2026-10-02) |
| 28 April 2023 | NDSN | A | 104 | $216,31 | $22.496 | 2.937 Langsung | +3,67% | Diakuisisi | 54,2% (harga per 2026-10-02) |
| 31 Jan. 2023 | NDSN | A | 92 | $243,30 | $22.384 | 2.818 Langsung | +3,37% | Diakuisisi | 37,1% (harga per 2026-10-02) |
| 1 Nov. 2022 | NDSN | A | 730 | $225,93 | $164.929 | 2.726 Langsung | +36,57% | Diakuisisi | 47,6% (harga per 2026-10-02) |
| 31 Okt. 2022 | NDSN | A | 100 | $225,00 | $22.500 | 1.996 Langsung | +5,27% | Diakuisisi | 48,2% (harga per 2026-10-02) |
| 29 Juli 2022 | NDSN | A | 97 | $230,99 | $22.406 | 1.891 Langsung | +5,41% | Diakuisisi | 44,4% (harga per 2026-10-02) |
| 29 April 2022 | NDSN | A | 104 | $215,69 | $22.432 | 1.790 Langsung | +6,17% | Diakuisisi | 54,6% (harga per 2026-10-02) |
| 31 Jan. 2022 | NDSN | A | 96 | $232,54 | $22.324 | 1.678 Langsung | +6,07% | Diakuisisi | 43,4% (harga per 2026-10-02) |
| 1 Nov. 2021 | NDSN | A | 608 | $238,43 | $144.965 | 1.582 Langsung | +62,42% | Diakuisisi | 39,9% (harga per 2026-10-02) |
| 29 Okt. 2021 | NDSN | A | 79 | $254,21 | $20.083 | 974 Langsung | +8,83% | Diakuisisi | 31,2% (harga per 2026-10-02) |
| 30 Juli 2021 | NDSN | A | 88 | $226,13 | $19.899 | 892 Langsung | +10,95% | Diakuisisi | 47,5% (harga per 2026-10-02) |
| 30 April 2021 | NDSN | A | 94 | $211,41 | $19.873 | 804 Langsung | +13,24% | Diakuisisi | 57,8% (harga per 2026-10-02) |
| 29 Jan. 2021 | NDSN | A | 85 | $178,99 | $15.214 | 707 Langsung | +13,67% | Diakuisisi | 86,3% (harga per 2026-10-02) |
| 23 Nov. 2020 | NDSN | A | 622 | $196,27 | $122.080 | 622 Langsung | · | Diakuisisi | 69,9% (harga per 2026-10-02) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II) Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 21 Jan. 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $94,15 | 21 Jan. 2036 | 15.000 | Diakuisisi |
| 23 Jan. 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $92,42 | 23 Jan. 2035 | 15.000 | Diakuisisi |
| 26 Jan. 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53,75 | 26 Jan. 2034 | 15.000 | Diakuisisi |
| 1 Sep. 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $54,23 | 1 Sep. 2033 | 15.000 | Diakuisisi |
| 1 Sep. 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $54,23 | 1 Sep. 2024 | 15.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 1 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 25 Nov. 2020 | NDSN | No Securities are Beneficially Owned | 0 | Langsung |